SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-20-219221
Filing Date
2020-08-13
Accepted
2020-08-13 16:47:18
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D d917691dsc13d.htm SC 13D 81449
2 EX-99.1 d917691dex991.htm EX-99.1 27045
  Complete submission text file 0001193125-20-219221.txt   110033
Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo Holdings A/S (Filed by) CIK: 0001388325 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Subject) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91617 | Film No.: 201099964
SIC: 2836 Biological Products, (No Diagnostic Substances)